Article as featured in the Financieel Dagblad (Financial Times), 29 November 2024 (link)
SuRE™ promoter screening: customizing your therapy for improved safety and efficacy
The development of cell and gene therapies is a complex and time-consuming process that depends on therapeutic genes being expressed in the right tissues, at the right time and at the right dosage.
